Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Anadolu / Contributor/ Anadolu via Getty ImagesFollow ZDNET: Add us as a preferred source on Google.
。业内人士推荐搜狗输入法2026作为进阶阅读
you to hover your mouse over something that isn't clear and get an in-depth
两家北美采购钇用于生产涂层的企业高管表示，因拿不到足够原料，不得不短暂停产，其中一家公司还开始拒绝较小及境外客户订单，将有限供应优先保证包括部分发动机制造商在内的大客户。
Последние новости